Our clinical team dug in, aligning the group with a value-based formulary that favors low-cost
generic alternatives over high-cost brand name drugs while still maintaining high quality patient.
Through strong contract management with pharmacies and manufacturers along with utilization
management procedures, we were able to provide this group even greater savings.
Our implemented cost containment strategies, including appropriate utilization management,
helped this group positively achieve balanced financial and clinical goals even with this new,
unexpected high-cost claimant.
By leveraging PBD’s unique relationship with our sister company and specialty pharmacy provider
Reliance Rx, we were able to manage targeted disease states and cost through innovative
programs like the Specialty Copay Assistance Program (SCAP) and disease-specific clinical
programs. Reliance Rx also provided comprehensive monitoring and outreach programs to help
deliver improved specialty drug outcomes for this group.